Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects
NCT02256826 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2014-10-06
Summary
To determine the pharmacokinetic effect of BILR 355 BS on Kaletra® and of Kaletra® on BILR 355 BS
Conditions
- Healthy
Interventions
- DRUG
-
BILR 355 BS
- DRUG
-
Ritonavir (RTV)
NORVIR®
- DRUG
-
Kaletra®
(lopinavir (LPV) and ritonavir (RTV))
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 59 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-04-30
- Primary Completion
- 2005-06-30
More Related Trials
-
Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Patients With Hepatic Impairment in Comparison to Healthy Volunteers
NCT02265627 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers
NCT02253953 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers
NCT02266550 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male Volunteers
NCT02183441 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers
NCT02257008 ·Status: COMPLETED ·Phase: PHASE1
-
Dose Escalation Study of Pharmacokinetics, Safety and Tolerability After Single Dose Administration of BILR 355 (SDS) Plus Low-dose Ritonavir in Healthy Volunteers
NCT02253927 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics/-Dynamics of Single Rising Doses BIBT 986 BS in Healthy Male Subjects
NCT02254057 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Pharmacodynamics, and Pharmacokinetics After Multiple Different Oral Doses of BIIB 722 CL Tablets in Healthy Volunteers
NCT02268604 ·Status: TERMINATED ·Phase: PHASE1
-
Investigation of Pharmacokinetics of BIBX 245 CL and Safety in Healthy Subjects
NCT02264197 ·Status: COMPLETED ·Phase: PHASE1
-
Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects
NCT02254083 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 11634 Solution in Healthy Male Volunteers
NCT02214914 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers
NCT02244190 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers
NCT02254538 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809
NCT02068690 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male Volunteers
NCT02183298 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.
NCT02183662 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects
NCT02253797 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Single Rising Doses of BI 685509
NCT02694354 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects
NCT04527484 ·Status: UNKNOWN ·Phase: PHASE1
-
Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers
NCT02222961 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers
NCT02259881 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Two Different Formulations of LY3209590 in Healthy Participants
NCT04768842 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3314814 in Participants With Liver Impairment
NCT03499041 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
NCT05515328 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Elderly Male and Female Volunteers
NCT02223507 ·Status: COMPLETED ·Phase: PHASE1